Acetylsalicylic acid Completed Phase 3 Trials for Noncardioembolic Cerebral Infarction Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01995370Cilostazol Stroke Prevention Study for Antiplatelet Combination